** Shares of the nutritional and personal care products
maker NATR.O rose as much as 7% to $9.7 in morning trade,
hitting over a 3-month high
** Set for a 3-day winning streak, if gains hold; stock
pares some gains, currently up 3% at $9.34
** NATR to enter the cannabidiol (CBD) market with a line of
hemp-derived CBD products
** CBD is a non-psychoactive chemical found in cannabis
plants that is known to ease anxiety and other illnesses without
causing a high
** Last year the FDA approved a CBD-based prescription drug
to treat forms of epilepsy urn:newsml:reuters.com:*:nL4N1TS05A
** Including session gains, stock up 17.2% this year
(Reporting by Bharath Manjesh in Bengaluru)
((Bharath.ManjeshR@thomsonreuters.com; outside U.S. +91 80
6749 8400;))